UK’s Cambridge-based Rapid Biosensor Systems (RBS) has developed a new screening test for early stage tuberculosis infection that is low cost, non-invasive and can be used in remote locations, since it does not require electricity or running water. The TB Breathalyser detects infected subjects capable of transmitting TB to others, giving a result in minutes with up 95% to accuracy.
The device, the result of six-year research and development program, consists of a collection tube, at the bottom of which is a glass bio-sensor coated with a patented bio-chemical coating that reacts with the TB bacilli. After the patient coughs into the tube, it is sealed with a simple twist action, and then inserted into a portable reader unit.